Milford, CT, United States of America

Joel Renick



Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 159(Granted Patents)


Location History:

  • West Haven, CT (US) (2002)
  • Milford, CT (US) (2007 - 2011)

Company Filing History:


Years Active: 2002-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Joel Renick

Introduction

Joel Renick is a notable inventor based in Milford, Connecticut, who has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Renick has focused on developing innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Renick has developed methods for the inhibition of RAF kinase using quinolyl, isoquinolyl, or pyridyl ureas. This invention relates to the use of a group of aryl ureas in treating RAF-mediated diseases, along with pharmaceutical compositions for such therapy. Another significant patent involves the use of ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors, which pertains to treating p38-mediated diseases and the pharmaceutical compositions utilized in this therapy.

Career Highlights

Throughout his career, Joel Renick has worked with prominent companies in the pharmaceutical industry, including Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Renick has collaborated with several professionals in his field, including William Johnston Scott and Roger Astbury Smith. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Joel Renick's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His innovative patents and collaborations reflect a dedication to improving treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…